Guo M, Liu C, Qi F J, et al. Elevated expression of nuclear protein kinase CK2α as a poor prognosis indicator in lymph node cancerous metastases of human thyroid cancers [J]. Asian Pac J Cancer Prev, 2014, 15(17): 7425-7432. [2]Litchfield D W. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death [J]. Biochem J, 2003, 369(Pt 1): 1-15. [3]Ahmad K A, Wang G, Unger G, et al. Protein kinase CK2--a key suppressor of apoptosis[J]. Adv Enzyme Regul, 2008, 48: 179-187. [4]Yao K, Youn H, Gao X, et al. Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells [J]. Prostate, 2012, 72(13): 1423-1430. [5]Stolarczyk E I, Reiling C J, Pickin K A, et al. Casein kinase 2α regulates multidrug resistance-associated protein 1 function via phosphorylation of Thr 249[J]. Mol Pharmacol, 2012, 82(3): 488-499. [6]Yang M, Sun H, He J, et al. Interaction of ribosomal protein L22 with casein kinase 2α: a novel mechanism for understanding the biology of non-small cell lung cancer [J]. Oncol Rep, 2014, 32(1): 139-144. [7]Hung M S, Xu Z, Chen Y, et al. Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model [J]. Int J Oncol, 2013, 43(5): 1517-1522. [8]Zhang S, Long H, Yang Y L, et al. Inhibition of CK2α down-regulates Notch1 signalling in lung cancer cells[J]. J Cell Mol Med, 2013, 17(7): 854-862. [9]Ryu B J, Baek S H, Kim J, et al. Anti-androgen receptor activity of apoptotic CK2 inhibitor CX4945 in human prostate cancer LNCap cells [J]. Bioorg Med Chem Lett, 2012, 22(17): 5470-5474. [10]Pallares J, Llobet D, Santacana M, et al. CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation[J]. Am J Pathol, 2009, 174(1): 287-296. [11]Guo C, Yu S, Davis A T, et al. A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells[J]. J Biol Chem, 2001, 276(8): 5992-5999. [12]Pinna L A. Protein kinase CK2: a challenge to canons[J]. J Cell Sci, 2002, 115(Pt 20): 3873-3878. [13]Deshiere A, Duchemin-Pelletier E, Spreux E, et al. Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction[J]. Oncogene, 2013, 32(11): 1373-1383. [14]Moucadel V, Prudent R, Sautel C F, et al. Antitumoral activity of allosteric inhibitors of protein kinase CK2[J]. Oncotarget, 2011, 2(12): 997-1010. [15]Adams J M. Ways of dying: multiple pathways to apoptosis[J] Genes Dev, 2003, 17(20): 2481-2495. [16]Son Y K, Lee S M, An W S, et al. The role of protein kinase CK2 in cyclosporine-induced nephropathy in rats[J]. Transplant Proc, 2013, 45(2): 756-762. [17]邹冬玲, 王冬, 刘海霞. Puma抑制卵巢癌细胞生长及其机制研究[J]. 第三军医大学学报, 2014, 36(14): 1477-1480.
